Edward P. Feener
CIK 1691090 · CHIEF SCIENTIFIC OFFICER · last filed 2024-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
38
Lifetime Open-Market Net
-$4.72M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | CHIEF SCIENTIFIC OFFICER | 72,858 | $27.00 | $1.97M | -$4.72M | 36 | 2024-05-21 |
Recent Filings · Page 3 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-28 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-07 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −6,000 | -$149.1K | EDGAR |
| 2021-05-06 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Mixed | — | -$87.8K | EDGAR |
| 2021-02-25 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −31,000 | -$1.04M | EDGAR |
| 2021-02-08 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2020-12-18 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-04 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −6,000 | -$102.8K | EDGAR |
| 2020-10-22 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −16,907 | -$303.0K | EDGAR |
| 2020-10-20 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −993 | -$16.9K | EDGAR |
| 2020-02-07 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −100 | -$1.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.